MedTrace Logo

Comparison of a Drug and Placebo in the Prevention of Migraine Headaches

NCT01122381 · Status: TERMINATED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2015-08-19

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether ethosuximide works better than placebo in the prevention of episodic migraine among veterans.

Conditions

  • Headache, Migraine

Interventions

DRUG

ethosuximide

ethosuximide (ESX)

OTHER

placebo comparator

placebo

Sponsors & Collaborators

Principal Investigators

  • Kathy L Gardner, MD · VA Pittsburgh Health Care System

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2014-04-30
Completion
2014-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01122381 on ClinicalTrials.gov